中文简体
中文简体
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文简体
中文简体
English
Search
Committed to Pioneering Innovation in Drug Development
ABOUT US
Putting Patients First, Innovation for All
Pursuing Excellence, Unwavering Persistence
R&D
Championing Patient Well-being,
Ensuring a Healthy Future
CAREERS
innovation
R&D
Precision Delivery Technology Platform
Beihai Biotech, with a global footprint and ambitious aspirations, has developed a Proprietary Precision Delivery Technology Platform.
Learn More
PDC Technology Platform
Beihai Biotech has developed a cutting-edge platform of Peptide-Drug Conjugate (PDC).
Learn More
A Robust Pipeline of 8 Promising Innovative Drug Candidates
Diverse Therapeutic Areas: Breast cancer, non-small cell lung cancer, prostate cancer, stomach cancer...
Learn More
Technology Platform
Pipelines
NEWS
NEWS
Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
Learn More
Beihai Biotech was awarded both the "VBEF AWARDS-MOST Innovative And Creative Products In Healthcare" and the "China Future Healthcare Rankings 2024-Top Biomedicine Companies"
Learn More
Beihai Biotechnology has won the Biotechnology Awards
Learn More
Beihai Biotech is listed on the PEdaily “2023 VENTURE 50” Life and Health Ranking
Learn More
See More
